Is now the time to buy these big tech stocks? Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
We’re going to cover the concept of “groupthink” and how it applies to your stock trading market decision. You’ll learn why it is important to focus on psychology when it comes to trading. How market behaves and moves is easy to understand if you know how people think. #tradingstocks #groupthink #stockcharts #investingdecisions #tradingdecisions Posted at:
0 Comments
J.C. Penney Company (JCP) is one of America’s oldest retailers but it’s hit a rough patch the last few years. Tracey Ryniec and David Bartosiak, Stock Strategists at Zacks Investment Research, discuss whether the company is in a turnaround and if it will survive. J.C. Penney has had a management problem for several years. New
0 Comments
Tracey Ryniec and David Bartosiak, Stock Strategists at Zacks Investment Research, discuss the future of chip maker Ambarella, Inc. (AMBA). Shares have plunged 35% from its all time highs earlier this summer on fears that the company may be a one-trick pony with GoPro (GPRO) as its most prominent customer. A rare earnings miss and
0 Comments
Nio (NIO) offers Tesla (TSLA) luxury without the production volumes. The company has stiff competition within China, and those competitors are now exporting. Nio will likely remain small, and investors should demand a profit. Source: Robert Way / Shutterstock.com At this point in the game, investing in Nio (NYSE:NIO) stock means investing in the Chinese
0 Comments
Twitter (TWTR) stock is still selling for $5/share less than Elon Musk’s offer. Musk has the money lined up thanks to SpaceX. What happens after the purchase isn’t your problem. Source: rafapress / Shutterstock.com Since Elon Musk said he would buy Twitter (NYSE:TWTR) for $54.20/share, about $44 billion, shares haven’t traded over $52. Twitter opened
0 Comments
Novavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated, demand for Novavax’s vaccine is likely to be weak. Rival pharmaceutical companies Pfizer and Moderna have beat Novavax to market with multiple Covid-19 treatments. Source: rarrarorro / Shutterstock.com Any hope
0 Comments
According to short-seller Hindenburg research, Mullen Automotive (NASDAQ:MULN) may be the next electric vehicle stock debacle. The news that Hindenburg Research has Mullen Automotive in its sights is not new. The short seller revealed its findings over a month ago. But those findings are worth revisiting as the stock continues to behave with volatility. Further,
0 Comments